84 related articles for article (PubMed ID: 8844688)
41. Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells.
Velcich A; Delli-Bovi P; Mansukhani A; Ziff EB; Basilico C
Oncogene Res; 1989; 5(1):31-7. PubMed ID: 2780052
[TBL] [Abstract][Full Text] [Related]
42. Angiogenic activity of the K-fgf/hst oncogene in neural transplants.
Brüstle O; Aguzzi A; Talarico D; Basilico C; Kleihues P; Wiestler OD
Oncogene; 1992 Jun; 7(6):1177-83. PubMed ID: 1375717
[TBL] [Abstract][Full Text] [Related]
43. Octamer-dependent regulation of the kFGF gene in embryonal carcinoma and embryonic stem cells.
Schoorlemmer J; Kruijer W
Mech Dev; 1991 Dec; 36(1-2):75-86. PubMed ID: 1723621
[TBL] [Abstract][Full Text] [Related]
44. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer.
Ambrosetti DC; Schöler HR; Dailey L; Basilico C
J Biol Chem; 2000 Jul; 275(30):23387-97. PubMed ID: 10801796
[TBL] [Abstract][Full Text] [Related]
45. SOX6 binds CtBP2 to repress transcription from the Fgf-3 promoter.
Murakami A; Ishida S; Thurlow J; Revest JM; Dickson C
Nucleic Acids Res; 2001 Aug; 29(16):3347-55. PubMed ID: 11504872
[TBL] [Abstract][Full Text] [Related]
46. Regulatory sequences required for hst-1 expression in embryonal carcinoma cells.
Koda T; Hasan S; Sasaki A; Arimura Y; Kakinuma M
FEBS Lett; 1994 Mar; 342(1):71-5. PubMed ID: 8143853
[TBL] [Abstract][Full Text] [Related]
47. An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cells.
Hasan S; Koda T; Kakinuma M
J Biol Chem; 1994 Oct; 269(40):25042-8. PubMed ID: 7929190
[TBL] [Abstract][Full Text] [Related]
48. Retinoic acid-regulated expression of fibroblast growth factor 3 requires the interaction between a novel transcription factor and GATA-4.
Murakami A; Thurlow J; Dickson C
J Biol Chem; 1999 Jun; 274(24):17242-8. PubMed ID: 10358083
[TBL] [Abstract][Full Text] [Related]
49. The artificial zinc finger protein 'Blues' binds the enhancer of the fibroblast growth factor 4 and represses transcription.
Libri V; Onori A; Fanciulli M; Passananti C; Corbi N
FEBS Lett; 2004 Feb; 560(1-3):75-80. PubMed ID: 14988001
[TBL] [Abstract][Full Text] [Related]
50. Identification of positive and negative regulatory elements involved in the retinoic acid/cAMP induction of Fgf-3 transcription in F9 cells.
Murakami A; Grinberg D; Thurlow J; Dickson C
Nucleic Acids Res; 1993 Nov; 21(23):5351-9. PubMed ID: 8265348
[TBL] [Abstract][Full Text] [Related]
51. Sequence analysis of the transcription control region upstream of the human FGF-3 gene.
Djenabi S; Brison O; Galdemard C; Lavialle C
DNA Seq; 1999; 10(4-5):317-29. PubMed ID: 10727086
[TBL] [Abstract][Full Text] [Related]
52. Cryptic promoter activity within the backbone of a plasmid commonly used to prepare promoter/reporter gene constructs.
Rosfjord E; Lamb K; Rizzino A
In Vitro Cell Dev Biol Anim; 1994 Jul; 30A(7):477-81. PubMed ID: 7952517
[TBL] [Abstract][Full Text] [Related]
53. Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor.
Lenardo MJ; Staudt L; Robbins P; Kuang A; Mulligan RC; Baltimore D
Science; 1989 Jan; 243(4890):544-6. PubMed ID: 2536195
[TBL] [Abstract][Full Text] [Related]
54. Expression and developmental regulation of the k-FGF oncogene in human and murine embryonal carcinoma cells.
Tiesman J; Rizzino A
In Vitro Cell Dev Biol; 1989 Dec; 25(12):1193-8. PubMed ID: 2481673
[TBL] [Abstract][Full Text] [Related]
55. Production and utilization of growth factors related to fibroblast growth factor by embryonal carcinoma cells and their differentiated cells.
Rizzino A; Kuszynski C; Ruff E; Tiesman J
Dev Biol; 1988 Sep; 129(1):61-71. PubMed ID: 2842210
[TBL] [Abstract][Full Text] [Related]
56. Functional characterization of the brain-specific FGF-1 promoter, FGF-1.B.
Myers RL; Ray SK; Eldridge R; Chotani MA; Chiu IM
J Biol Chem; 1995 Apr; 270(14):8257-66. PubMed ID: 7713933
[TBL] [Abstract][Full Text] [Related]
57. DNA sequence and nucleosome placement on the murine fibroblast growth factor-4 gene.
Wilder PJ; Mountjoy C; Macleod MC; Rizzino A
DNA Seq; 1997; 7(2):117-21. PubMed ID: 9063648
[TBL] [Abstract][Full Text] [Related]
58. Identification of a candidate enhancer for DMRT3 involved in spastic cerebral palsy pathogenesis.
Kubota N; Yokoyama T; Hoshi N; Suyama M
Biochem Biophys Res Commun; 2018 Jan; 496(1):133-139. PubMed ID: 29305858
[TBL] [Abstract][Full Text] [Related]
59. Expression of multiple heparin-binding growth factor species by murine embryonal carcinoma and embryonic stem cells.
Heath JK; Paterno GD; Lindon AC; Edwards DR
Development; 1989 Sep; 107(1):113-22. PubMed ID: 2627890
[TBL] [Abstract][Full Text] [Related]
60. Expression of the fibroblast growth factor 4 (FGF-4) gene is regulated by serum in Tera-2 embryonal carcinoma cells.
Lucas J; Knobloch T; Lang J
Int J Oncol; 1996 Feb; 8(2):377-81. PubMed ID: 21544372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
